Solvonis Therapeutics PLCLSE: SVNS

Corporate Presentation

· Issued by Solvonis Therapeutics PLC

20 March 2023

Graft Polymer (UK) Plc

("Graft Polymer", the "Company", and together with its subsidiaries, the "Group")

New Corporate Presentation     

Graft Polymer (UK) Plc (LSE: GPL), a business focused on the development and commercial production of polymer modification, biological supplements, and nano-drug delivery systems, is pleased to announce that an updated corporate presentation is now available on its website:   https://graftpolymer.com/ .

**ENDS**

For more information, please visit        https://www.graftpolymer.com      or contact:

Graft Polymer (UK) Plc

via St Brides Partners

Roby Zomer, Chairman

Yifat Steuer, CFO

Turner Pope Investments (Broker)

+44 20 3657 0050

James Pope

Andy Thacker

St Brides Partners (Public Relations)

Catherine Leftley

graftpolymer@stbridespartners.co.uk

Ana Ribeiro

Max Bennett

Solvonis Therapeutics PLC on 6ix

Story so far

Earlier from Solvonis Therapeutics

Later from Solvonis Therapeutics

All Solvonis Therapeutics news releases